US Stock MarketDetailed Quotes

TYPTF TRYPTAMINE THERAPEUTICS LIMITED

Watchlist
  • 0.025
  • +0.005+24.13%
15min DelayClose Dec 18 16:00 ET
31.85MMarket Cap-1.08P/E (TTM)

About TRYPTAMINE THERAPEUTICS LIMITED Company

Tryptamine Therapeutics Ltd. is a clinical-stage biotechnology company, which engages in investing in biopharmaceutical drug development. The company was headquartered in Camberwell, Australia.

Company Profile

SymbolTYPTF
Company NameTRYPTAMINE THERAPEUTICS LIMITED
MarketPink Market
Employees50
Fiscal Year Ends06-30
Address697 Burke Road,Suite 201
CityCamberwell
ProvinceVictoria (VIC)
CountryAustralia
Zip Code3124

Company Executives

  • Name
  • Position
  • Salary
  • Peter Molloy
  • Chief Business Officer and Executive Director,Non-Executive Director
  • --
  • Mark Davies
  • Non-Executive Chairman,Non-Executive Director
  • --
  • Clarke Barlow
  • Non-Executive Director
  • --
  • Christopher Ntoumenopoulos
  • Non-Executive Director
  • --
  • Jason Carroll
  • Non-Executive Director
  • --
  • Gage Jull
  • Non-Executive Director
  • --
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.